Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
176M
-
Number of holders
-
72
-
Total 13F shares, excl. options
-
81.5M
-
Shares change
-
+1.66M
-
Total reported value, excl. options
-
$267M
-
Value change
-
+$1.8M
-
Number of buys
-
49
-
Number of sells
-
-17
-
Price
-
$3.27
Significant Holders of Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) as of Q1 2023
78 filings reported holding CMPX - Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q1 2023.
Compass Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CMPX) has 72 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.5M shares
of 176M outstanding shares and own 46.21% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (22.4M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (6.25M shares), JANUS HENDERSON GROUP PLC (6M shares), FMR LLC (5.68M shares), Rock Springs Capital Management LP (5.51M shares), Blackstone Inc. (4.62M shares), VANGUARD GROUP INC (3.69M shares), Vivo Capital, LLC (3.56M shares), Foresite Capital Management V, LLC (3.48M shares), and BRAIDWELL LP (3.25M shares).
This table shows the top 72 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.